or Try an Advanced Search...

    Technical Analysis for CRDL - Cardiol Therapeutics Inc

    Grade Last Price % Change Price Change
    F 2.150 -4.87% -0.110
    CRDL closed up 1.8 percent on Friday, November 22, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CRDL trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish -4.87%
    NR7 Range Contraction -4.87%
    Lower Bollinger Band Walk Weakness -4.87%
    Lower Bollinger Band Touch Weakness -4.87%
    Oversold Stochastic Weakness -4.87%
    Hammer Candlestick Bullish -3.15%
    Lizard Bullish Bullish Day Trade Setup -3.15%
    Lower Bollinger Band Walk Weakness -3.15%
    Below Lower BB Weakness -3.15%
    Lower Bollinger Band Touch Weakness -3.15%
    Older End-of-Day Signals for CRDL ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 2 hours ago
    Fell Below Lower Bollinger Band about 2 hours ago
    Fell Below Previous Day's Low about 3 hours ago
    Lower Bollinger Band Support about 4 hours ago
    Down 3% about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    CRDL Chart by TradingView
    Basic chart:

    Profile

    Cardiol Therapeutics Inc Description

    Cardiol Therapeutics Inc is a Canada-based company engaged in the pharmaceutical business sector. The Company is focused on the research and commercial development of pharmaceutical cannabidiol products and targeted therapies for heart failure and cancer. It has research programs focused on development of nanotherapeutics to treat heart failure underway. The Company invests in development of formulations for three medical markets: commercializing a line of purity pharmaceutically-manufactured cannabidiol products in the market for medical cannabinoids; development of nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs for the treatment of heart failure, a cause of death and hospitalization, and pursuing an immunotherapeutics program commencing with a cancer immunotherapeutic in combination with cannabinoids for treating Glioblastoma Multiforme.

    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharma Pharmaceutical Drug Cancer Drugs Heart Organ Systems Cannabinoid Blastoma Cannabidiol Cannabinoids Glioblastoma Pharmaceutical Business Sector

    Is CRDL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 10 Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024
    Jul 12 We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate
    Jun 27 Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders
    Jun 25 Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT
    Jun 17 Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
    Jun 13 Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
    See more CRDL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.26
    52 Week Low 1.07
    Average Volume 121,823
    200-Day Moving Average 2.676
    50-Day Moving Average 2.684
    20-Day Moving Average 2.560
    10-Day Moving Average 2.469
    Average True Range 0.165
    RSI (14) 34.64
    ADX 19.44
    +DI 16.281
    -DI 27.595
    Chandelier Exit (Long, 3 ATRs) 2.445
    Chandelier Exit (Short, 3 ATRs) 2.555
    Upper Bollinger Bands 2.935
    Lower Bollinger Band 2.185
    Percent B (%b) 0.1
    BandWidth 29.291
    MACD Line -0.104
    MACD Signal Line -0.054
    MACD Histogram -0.0492
    Fundamentals Value
    Market Cap 74.16 Million
    Num Shares 32.8 Million
    EPS -1.02
    Price-to-Earnings (P/E) Ratio -2.22
    Price-to-Sales 0.00
    Price-to-Book 3.94
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.440
    Resistance 3 (R3) 2.433 2.367 2.410
    Resistance 2 (R2) 2.367 2.321 2.370 2.400
    Resistance 1 (R1) 2.313 2.293 2.320 2.320 2.390
    Pivot Point 2.247 2.247 2.250 2.250 2.247
    Support 1 (S1) 2.193 2.201 2.200 2.200 2.130
    Support 2 (S2) 2.127 2.173 2.130 2.120
    Support 3 (S3) 2.073 2.127 2.110
    Support 4 (S4) 2.080